Calcium Supplementation to Prevent Preeclampsia in Sichuan Province of China
Calcium Supplementation to Prevent Preeclampsia in Sichuan Province of China: a Multi-center, Prospective Random Trial
Sponsor: Chengdu Women's and Children's Central Hospital
A NA clinical study on Preeclampsia, this trial is ongoing. The trial is conducted by Chengdu Women's and Children's Central Hospital and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Jun 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Jun 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chengdu Women's and Children's Central Hospital
- Guang'an people's hospital of Sichuan province
- Sichuan Academy of Medical Sciences
- Sichuan Provincial Maternal and Child Health Care Hospital
- Suining Central Hospital
- The First People's Hospital of Neijiang
- West China Second University Hospital
- pengzhou shi fuyou baojianyuan
For direct contact, visit the study record on ClinicalTrials.gov .